New York, NY, United States of America

Zhan Yao

This inventor holds 1 USPTO granted patent. Top assignees: Cold Spring Harbor Laboratory, Rutgers, The State University of New Jersey. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhan Yao. Retrieved from https://idiyas.com/inventor/zhan-yao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Zhan Yao: Innovator in Cancer Research**

Introduction

Zhan Yao is a prominent inventor based in New York, NY, recognized for his contributions to cancer research. With a focus on methods and compositions that inhibit growth and epithelial to mesenchymal transition (EMT) in cancer cells, his work plays a significant role in understanding and battling cancer progression.

Latest Patents

Zhan Yao holds one patent titled "Methods and compositions for inhibiting growth and epithelial to mesenchymal transition (EMT) in cancer cells." This patent outlines novel methods and compositions aimed at inhibiting the epithelial to mesenchymal transition of cells, which is a critical process in cancer metastasis.

Career Highlights

Zhan has worked with notable institutions such as Cold Spring Harbor Laboratory and Rutgers, The State University of New Jersey. His experience in these esteemed organizations has enhanced his research skills and contributed to his innovative work in cancer therapies.

Collaborations

Throughout his career, Zhan Yao has collaborated with esteemed colleagues, including Raffaella Sordella and Serif Senturk. These partnerships have allowed for the exchange of ideas and the advancement of research in cancer treatment methodologies.

Conclusion

Zhan Yao stands out as an influential figure in the realm of cancer research, with his patent representing a significant step forward in inhibiting cancer cell proliferation and transition. His expertise and collaborations continue to impact the field positively, paving the way for future innovations in cancer therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…